摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-溴苯基)-3-(二甲基氨基)-2-丙烯-1-酮 | 73387-60-7

中文名称
1-(4-溴苯基)-3-(二甲基氨基)-2-丙烯-1-酮
中文别名
——
英文名称
(2E)-1-(4-bromophenyl)-3-(dimethylamino)prop-2-en-1-one
英文别名
(E)-1-(4-bromophenyl)-3-(dimethylamino)prop-2-en-1-one;1-(4-bromophenyl)-3-dimethylamino-2-propen-1-one
1-(4-溴苯基)-3-(二甲基氨基)-2-丙烯-1-酮化学式
CAS
73387-60-7
化学式
C11H12BrNO
mdl
——
分子量
254.126
InChiKey
IGZLESKZUATMSD-BQYQJAHWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    80-82℃
  • 沸点:
    319.4±42.0 °C(Predicted)
  • 密度:
    1.355±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2922399090

SDS

SDS:0fe405052061b8c3bd005b3c90b9f657
查看
Material Safety Data Sheet

Section 1. Identification of the substance
(2E)-1-(4-Bromophenyl)-3-(dimethylamino)prop-2-en-1-one
Product Name:
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
(2E)-1-(4-Bromophenyl)-3-(dimethylamino)prop-2-en-1-one
Ingredient name:
CAS number: 73387-60-7

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C11H12BrNO
Molecular weight: 254.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-溴苯基)-3-(二甲基氨基)-2-丙烯-1-酮磺酰氯 作用下, 反应 0.17h, 以15%的产率得到4-溴苯甲酸
    参考文献:
    名称:
    Neue Synthese aromatischer Carbonsäuren aus Enaminonen
    摘要:
    DOI:
    10.1002/ardp.19953280315
  • 作为产物:
    描述:
    4-溴苯乙酮N,N-二甲基甲酰胺二甲基缩醛 反应 5.0h, 以91%的产率得到1-(4-溴苯基)-3-(二甲基氨基)-2-丙烯-1-酮
    参考文献:
    名称:
    一系列新颖的吡唑并[1,5-a]嘧啶取代的二酰胺衍生物的设计,合成和抗癌评估
    摘要:
    使用线性模式多步合成法设计并合成了一系列新颖的吡唑并[1,5-a]嘧啶取代的二酰胺。合成的化合物通过1 H NMR,13 C NMR,ESI-MS和IR分析进行表征。使用MTT分析法筛选了这些新化合物的体外抗增殖活性。在当前研究中合成的23种衍生物中,化合物10q,10u和10w对HeLa细胞系显示出良好的抗癌活性。此外,这些衍生物对HeLa细胞的IC 50值小于10 µM,因此比市售的抗癌药顺铂(17.83 µM)更有效。
    DOI:
    10.1007/s00044-016-1770-0
点击查看最新优质反应信息

文献信息

  • [EN] PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH<br/>[FR] DÉRIVÉS DE PYRAZOLE UTILES COMME INHIBITEURS DE FAAH
    申请人:MERCK & CO INC
    公开号:WO2009151991A1
    公开(公告)日:2009-12-17
    The present invention is directed to certain imidazole derivatives which are useful as inhibitors of Fatty Acid Amide Hydrolase (FAAH). The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer disease, and Parkinson's disease
    本发明涉及某些咪唑衍生物,其可用作脂肪酰胺水解酶(FAAH)的抑制剂。该发明还涉及包含这些化合物作为活性成分的药物配方,以及这些化合物及其配方在治疗某些疾病中的使用,包括骨关节炎、类风湿性关节炎、糖尿病神经病变、带状疱疹后神经痛、骨骼肌肉疼痛和纤维肌痛,以及急性疼痛、偏头痛、睡眠障碍、阿尔茨海默病和帕金森病。
  • [EN] 4,4A,5,7,8,8A-HEXAPYRIDO[4,3-B][1,4]OXAZIN-3-ONE COMPOUNDS AS MAGL INHIBITORS<br/>[FR] COMPOSÉS 4,4A,5,7,8,8 A-HEXAPYRIDO [4,3-B] [1,4] OXAZIN-3-ONE EN TANT QU'INHIBITEURS DE MAGL
    申请人:HOFFMANN LA ROCHE
    公开号:WO2021048242A1
    公开(公告)日:2021-03-18
    The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L1, X, m, n, and R1 to R7 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as monoacylglycerol lipase (MAGL) inhibitors.
    这项发明提供了具有一般式(I)的新杂环化合物,其中A、B、L1、X、m、n以及R1到R7如本文所述,包括这些化合物的组合物,制造这些化合物的方法以及将这些化合物用作单酰基甘油酶(MAGL)抑制剂的方法。
  • Directed C–C bond cleavage of a cyclopropane intermediate generated from<i>N</i>-tosylhydrazones and stable enaminones: expedient synthesis of functionalized 1,4-ketoaldehydes
    作者:Meiyan Ni、Jianguo Zhang、Xiaoyu Liang、Yaojia Jiang、Teck-Peng Loh
    DOI:10.1039/c7cc07178g
    日期:——
    -quaternary centers via regioseletive C-C bond activation has been described. Through cyclopropanation of bench-stable enaminones with in situ generated diazo reagents from N-tosylhydrazones, followed by selective C-C bond cleavage of the cyclopropane ring affords the 1, 4-ketoaldehyde derivatives in good to excellent yields. This method works with broad substrate scope and high regioseletivity.
    已经描述了一种有效的方法,该方法通过区域选择性CC键活化来构建带有全碳原子的α-季中心的官能化的1,4-酮醛。通过使用原位生成的N-甲苯磺酰hydr酮重氮试剂对稳定的烯胺酮进行环丙烷化,然后选择性地将CC裂解成环丙烷环,可得到1,4-酮醛衍生物,收率好至极佳。该方法适用于较宽的底物范围和较高的重复性。
  • Highly Site-Selective Metal-Free C–H Acyloxylation of Stable Enamines
    作者:Fei Wang、Wangbing Sun、Yixin Wang、Yaojia Jiang、Teck-Peng Loh
    DOI:10.1021/acs.orglett.8b00222
    日期:2018.2.16
    A highly site-selective acyloxylation of stable enamines with PhI(OAc)2 under metal-free conditions to afford (E)-vinyl acetate derivatives in good to excellent yields is described. Depending on the judicious choice of the solvent system, either the α- or β-site-selective product could be obtained with high selectivity. For the α-site-selective product, the rearranged amide compound is obtained as
    描述了在无金属条件下用Phi(OAc)2对稳定的烯胺进行高度位点选择性的酰氧基化,从而以良好或优异的收率得到(E)-乙酸乙烯酯衍生物。取决于溶剂系统的明智选择,可以高选择性获得α-位或β-位选择性产物。对于α-位选择产物,获得了重排的酰胺化合物作为主要产物。该反应在温和的反应条件下(室温,无金属和烧瓶)进行,并且具有广泛的底物范围。
  • Synthesis of Polyaromatic Rings: Rh(III)-Catalyzed [5 + 1] Annulation of Enaminones with Vinyl Esters through C–H Bond Functionalization
    作者:Gaohui Liang、Jiaxin Rong、Wangbin Sun、Gengjia Chen、Yaojia Jiang、Teck-Peng Loh
    DOI:10.1021/acs.orglett.8b03284
    日期:2018.11.16
    An expedient [5 + 1] annulation method via Rh(III)-catalyzed C–H bond functionalization of enaminones to synthesize polyaromatic rings is described. The reaction tolerates a broad range of functional groups and offers a new entry to construct polycyclic aromatic compounds with amino and formyl substituents. A possible reaction mechanism was proposed based on the results obtained from isotope labeling
    描述了通过Rh(III)催化烯胺酮的C–H键官能化合成聚芳环的简便方法[5 +1]。该反应可耐受各种官能团,并为构建具有氨基和甲酰基取代基的多环芳族化合物提供了新的契机。根据同位素标记实验的结果,提出了可能的反应机理。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐